Adequan is an FDA-approved injectable drug primarily utilized for treating arthritis in dogs. It is considered a disease-modifying osteoarthritis drug (DMOAD). Unlike traditional pain relievers that ...

The Food and Drug Administration is warning veterinarians about deaths, debilitating neurological issues and other side effects that followed use of a popular arthritis drug for dogs. The agency said, ...

A popular drug for dogs with arthritis may be associated with a variety of potentially severe neurological effects, including seizures and a loss of muscle control, according to a recent review by the ...

Around the country, veterinarians are prescribing a breakthrough new arthritis drug for dogs — Librela — which is helping aging pets get moving again by easing the aches and pains of osteoarthritis.

The agency recommended that the maker of Librela update its label to reflect the possibility of more serious adverse reactions. By Emily Anthes A popular drug for dogs with arthritis may be associated ...